Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 8/20 | 1.00 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.68 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.68 |
| ▸ | FAAH | O00519 | 1/20 | 0.54 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | LCK | P06239 | 1/20 | 0.50 |
| ▸ | PPARD | Q03181 | 1/20 | 0.50 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.50 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL310070 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4FAAHSLC22A6 | |
| SCHEMBL155391 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4FAAHSLC22A6 | |
| SCHEMBL4916940 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4FAAHSLC22A6 | |
| SCHEMBL311217 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4FAAHSLC22A6 | |
| SCHEMBL7077603 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4FAAHSLC22A6 | |
| SCHEMBL23698920 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4FAAHSLC22A6 | |
| SCHEMBL311718 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4FAAHSLC22A6 | |
| SCHEMBL1268124 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4FAAHSLC22A6 | |
| SCHEMBL7080958 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4FAAHSLC22A6 | |
| SCHEMBL8441815 | 1.00 | GPR84 (1.00) | GPR84FFAR1FFAR4FAAHSLC22A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150305899-A1 | BRANCHED POLYHYDROXYALKANOATE SYSTEMS FOR BIORESORBABLE VASCULAR SCAFFOLD APPLICATIONS | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2015-10-29 | — | — | US | claimed |
| US-20250258146-A1 | QUANTITATIVE DETECTION METHOD OF MULTIPLE METABOLITES IN BIOLOGICAL SAMPLE AND METABOLIC CHIP | HUMAN METABOLOMICS INSTITUTE INC. (CN) | 2025-08-14 | — | — | US | disclosed |
| US-20240384313-A1 | METHODS OF PRODUCING POLYOL LIPIDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-11-21 | — | — | US | disclosed |
| US-12031173-B2 | Methods of producing polyol lipids | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-07-09 | — | — | US | disclosed |
| EP-4252004-A1 | BIOMARKERS FOR MYCOBACTERIUM AVIUM PARATUBERCULOSIS | Aberystwyth University (GB) | 2023-10-04 | — | — | EP | disclosed |
| US-20220325305-A1 | METHODS OF PRODUCING POLYOL LIPIDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-10-13 | — | — | US | disclosed |
| US-11401539-B2 | Methods of producing polyol lipids | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-08-02 | — | — | US | disclosed |
| WO-2022112763-A1 | BIOMARKERS FOR MYCOBACTERIUM AVIUM PARATUBERCULOSIS | ABERYSTWYTH UNIVERSITY (GB) | 2022-06-02 | — | — | WO | disclosed |
| US-20190119707-A1 | METHODS OF PRODUCING POLYOL LIPIDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-04-25 | — | — | US | disclosed |
| WO-2017184884-A1 | METHODS OF PRODUCING POLYOL LIPIDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-10-26 | — | — | WO | disclosed |
| EP-1176135-B1 | Process for producing optically active alcohol | TAKASAGO PERFUMERY CO LTD (JP) | 2005-06-15 | — | — | EP | disclosed |
| EP-0920852-B1 | Keratin fiber strengthening agent and method for strengthening keratin fiber | TAKASAGO PERFUMERY CO LTD (JP) | 2005-06-01 | — | — | EP | disclosed |
| EP-0856510-B1 | Optically active ceramides and process for producing the same | TAKASAGO PERFUMERY CO LTD (JP) | 2002-12-11 | — | — | EP | disclosed |
| US-6492545-B2 | Process for producing optically active alcohol | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-12-10 | — | — | US | disclosed |
| US-6379659-B1 | APPLYING (2S,3R)-2-ACYLAMINOALKANE-1,3-DIOL TO FIBER | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-04-30 | — | — | US | disclosed |
| US-20020035283-A1 | Process for producing optically active alcohol | TAKASAGO INTERNATIONAL CORPORATION | 2002-03-21 | — | — | US | disclosed |
| EP-1176135-A1 | Process for producing optically active alcohol | Takasago International Corporation (JP) | 2002-01-30 | — | — | EP | disclosed |
| US-5998668-A | Optically active compound and process for producing the same | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1999-12-07 | — | — | US | disclosed |
| EP-0920852-A2 | Keratin fiber strengthening agent and method for strengthening keratin fiber | Takasago International Corporation (JP) | 1999-06-09 | — | — | EP | disclosed |
| EP-0856510-A1 | Optically active ceramides and process for producing the same | Takasago International Corporation (JP) | 1998-08-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020035283-A1 | Process for producing optically active alcohol | ADH1A, ADH5, ADH1C | GPR84 868/4885FFAR1 413/4885FFAR4 549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.